Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Bloomberg View

The Crucial Tests for Obamacare

The Crucial Tests for Obamacare

Photograph by Gallery Stock

Now that the March 31 deadline for people to sign up for health insurance has passed, brace yourself for a lot of political kvetching. Supporters will claim that the late surge in enrollment proves the Affordable Care Act is a success, while opponents will counter that continued technical glitches and last-minute changes show the law to be a failure.

That’s background noise: The real challenge is to respond to at least three kinds of concerns. The first involves problems with the law itself. Many state-run exchanges are poorly run; states such as Maryland and Massachusetts need help to fix them in time for the next open enrollment period, which starts in November. The law’s programs to cushion insurers from excess risk may also need reinforcement—if not enough young people sign up for insurance—to lessen any shocks to premiums next year.

There are also challenges with the health-care system generally. These include persuading still more young people to sign up next time; getting more doctors and hospitals to coordinate care; making good on the promise to make medicine more affordable; and smoothing the transition from employer-based coverage for people who lose it.

None of this occurs in a political vacuum, of course, and this is the last and most expansive challenge. If the Affordable Care Act could be said to have a single purpose, it would be to extend health-care insurance to people who cannot afford it. That said, it has proved difficult to expand coverage to poor people in states that reject the law. Some states may well follow New Hampshire’s lead, reversing their initial opposition to the expansion of Medicaid.

But if the federal government’s current strategy of exemptions and semantic dodges proves unequal to the task of gaining Obamacare purchase in states such as Texas or North Carolina, its architects will need to look for an alternative. Spending $1.3 trillion on health-care subsidies for the middle class while leaving many poorer Americans with no options threatens the moral basis for the whole undertaking.

To read Jonathan Mahler on Donald Trump’s NFL and Mark Buchanan on messy capitalism, go to:

blog comments powered by Disqus